United States · FDA National Drug Code directory
Uceris
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68012-309_250346dc-e6de-b148-e063-6394a90a1ca3
- Product NDC
- 68012-309
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- budesonide
- Labeler
- Santarus Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130114
- Source listing expiry
- 20261231
Source-listed ingredients
- BUDESONIDE — 9 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (68012-309-01) · 68012-309-01
- 2 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (68012-309-02) · 68012-309-02
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68012-309-30) · 68012-309-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →